sarsasapogenin and Diabetic Nephropathies
sarsasapogenin has been researched along with Diabetic Nephropathies in 3 studies
Research
Studies (3)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 2 (66.67) | 2.80 |
Authors
Authors | Studies |
---|---|
Huang, TT; Liu, YW; Ma, TF; Tang, ZZ; Zhang, YM; Zheng, T | 1 |
Du, L; Jiang, H; Li, CL; Li, XZ; Liu, YQ; Liu, YW; Lu, Q; Shi, JS; Tang, JW; Wang, X; Xu, L; Yin, XX; Yu, XJ | 1 |
Chen, YJ; Hao, YC; Kong, L; Liu, YW; Wang, TY; Yin, SY; Zhang, MY | 1 |
Other Studies
3 other study(ies) available for sarsasapogenin and Diabetic Nephropathies
Article | Year |
---|---|
Sarsasapogenin alleviates diabetic nephropathy through suppression of chronic inflammation by down-regulating PAR-1: In vivo and in vitro study.
Topics: Animals; Blood Glucose; Cells, Cultured; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Down-Regulation; Humans; Inflammasomes; Kidney; Male; Mesangial Cells; Nephritis; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Rats, Sprague-Dawley; Receptor, PAR-1; Spirostans; Thrombin | 2020 |
Sarsasapogenin restores podocyte autophagy in diabetic nephropathy by targeting GSK3β signaling pathway.
Topics: Animals; Autophagy; Diabetic Nephropathies; Drug Delivery Systems; Drugs, Chinese Herbal; Glycogen Synthase Kinase 3 beta; Male; Podocytes; Rats; Rats, Sprague-Dawley; Signal Transduction; Spirostans | 2021 |
Protective effects of sarsasapogenin against early stage of diabetic nephropathy in rats.
Topics: Anemarrhena; Animals; China; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Drugs, Chinese Herbal; Glycation End Products, Advanced; Interleukin-18; Kidney; Male; NLR Family, Pyrin Domain-Containing 3 Protein; Rats; Rats, Sprague-Dawley; Rhizome; Saponins; Spirostans; Uric Acid | 2018 |